title: Akt1 binds focal adhesion kinase via the Akt1 kinase domain independently of the pleckstrin homology domain.
abstract: Akt1 and focal adhesion kinase (FAK) are protein kinases that play key roles in normal cell signaling. Individually, aberrant expression of these kinases has been linked to a variety of cancers. Together, Akt1/FAK interactions facilitate cancer metastasis by increasing cell adhesion under conditions of increased extracellular pressure. Pathological and iatrogenic sources of pressure arise from tumor growth against constraining stroma or direct perioperative manipulation. We previously reported that 15 mmHg increased extracellular pressure causes Akt1 to both directly interact with FAK and to phosphorylate and activate it. We investigated the nature of the Akt1/FAK binding by creating truncations of recombinant FAK, conjugated to glutathione S-transferase (GST), to pull down full-length Akt1. Western blots probing for Akt1 showed that FAK/Akt1 binding persisted in FAK truncations consisting of only amino acids 1-126, FAK(NT1), which contains the F1 subdomain of its band 4.1, ezrin, radixin, and moesin (FERM) domain. Using FAK(NT1) as bait, we then pulled down truncated versions of recombinant Akt1 conjugated to HA (human influenza hemagglutinin). Probes for GST-FAK(NT1) showed Akt1-FAK binding to occur in the absence of the both the Akt1 (N)-terminal pleckstrin homology (PH) domain and its adjacent hinge region. The Akt1 (C)-terminal regulatory domain was equally unnecessary for Akt1/FAK co-immunoprecipitation. Truncations involving the Akt1 catalytic domain showed that the domain by itself was enough to pull down FAK. Additionally, a fragment spanning from the PH domain to half way through the catalytic domain demonstrated increased FAK binding compared to full length Akt1. These results begin to delineate the Akt1/FAK interaction and can be used to manipulate their force-activated signal interactions. Furthermore, the finding that the N-terminal half of the Akt1 catalytic domain binds so strongly to FAK when cleaved from the rest of the protein may suggest a means for developing novel inhibitors that target this specific Akt1/FAK interaction.
authors.affiliation: Department of Surgery, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, USA. marc.basson@med.und.edu.|Department of Basic Science, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, USA.
authors.forename: M D
authors.initials: MD
authors.lastname: Basson
authors.affiliation: Department of Surgery, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, USA.
authors.forename: B
authors.initials: B
authors.lastname: Zeng
authors.affiliation: Department of Surgery, University of North Dakota, School of Medicine and Health Sciences, Grand Forks, USA.
authors.forename: S
authors.initials: S
authors.lastname: Wang
mesh_terms: D001798:Blood Proteins / Q000378:metabolism*; D015153:Blotting, Western; D018938:Caco-2 Cells; D003110:Colonic Neoplasms / Q000473:pathology*; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000378:metabolism*; D005982:Glutathione Transferase / Q000378:metabolism; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000378:metabolism; D006801:Humans; D010750:Phosphoproteins / Q000378:metabolism*; D010766:Phosphorylation; D011485:Protein Binding; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*
chemical_list: D001798:Blood Proteins; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D010750:Phosphoproteins; C039077:platelet protein P47; D005982:Glutathione Transferase; D051416:Focal Adhesion Protein-Tyrosine Kinases; C494918:AKT1 protein, human; D051057:Proto-Oncogene Proteins c-akt